顯示第 1 至 16 項結果,共 48 項
-
Anti-CEA [CH1A1A (2F1, CH1A1A-2F1)] (Ab02721-1.1-BT)
-
Anti-CEA [CH1A1A (2F1, CH1A1A-2F1)] (Ab02721-1.1)
-
Anti-CEA [CH1A1A (2F1, CH1A1A-2F1)] (Ab02721-10.0-BT)
-
Anti-CEA [CH1A1A (2F1, CH1A1A-2F1)] (Ab02721-10.0)
-
Anti-CEA [CH1A1A (2F1, CH1A1A-2F1)] (Ab02721-10.3-BT)
-
Anti-CEA [CH1A1A (2F1, CH1A1A-2F1)] (Ab02721-10.3)
-
Anti-CEA [CH1A1A (2F1, CH1A1A-2F1)] (Ab02721-23.0-BT)
-
Anti-CEA [CH1A1A (2F1, CH1A1A-2F1)] (Ab02721-23.0)
-
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] (Ab00103-10.0-BT)
-
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] (Ab00103-10.0)
-
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] (Ab00103-10.26-BT)
-
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] (Ab00103-10.26)
-
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] (Ab00103-10.3-BT)
-
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] (Ab00103-10.3)
-
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] (Ab00103-10.6-BT)
-
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] (Ab00103-10.6)
